106 related articles for article (PubMed ID: 24766601)
1. Nasopharyngeal cancer-specific therapy based on fusion peptide-functionalized lipid nanoparticles.
Luo H; Lu L; Yang F; Wang L; Yang X; Luo Q; Zhang Z
ACS Nano; 2014 May; 8(5):4334-47. PubMed ID: 24766601
[TBL] [Abstract][Full Text] [Related]
2. Curcumin loaded sub-30 nm targeting therapeutic lipid nanoparticles for synergistically blocking nasopharyngeal cancer growth and metastasis.
Luo H; Lu L; Liu N; Li Q; Yang X; Zhang Z
J Nanobiotechnology; 2021 Jul; 19(1):224. PubMed ID: 34320999
[TBL] [Abstract][Full Text] [Related]
3. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
4. A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis.
Li N; Feng L; Han HQ; Yuan J; Qi XK; Lian YF; Kuang BH; Zhang YC; Deng CC; Zhang HJ; Yao YY; Xu M; He GP; Zhao BC; Gao L; Feng QS; Chen LZ; Yang L; Yang D; Zeng YX
Cancer Lett; 2016 Oct; 381(1):14-22. PubMed ID: 27424523
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis by high-dose gold nanoparticles in nasopharyngeal carcinoma cells.
Lan MY; Hsu YB; Hsu CH; Ho CY; Lin JC; Lee SW
Auris Nasus Larynx; 2013 Dec; 40(6):563-8. PubMed ID: 23722198
[TBL] [Abstract][Full Text] [Related]
6. Scavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles.
Zheng Y; Liu Y; Jin H; Pan S; Qian Y; Huang C; Zeng Y; Luo Q; Zeng M; Zhang Z
Theranostics; 2013; 3(7):477-86. PubMed ID: 23843895
[TBL] [Abstract][Full Text] [Related]
7. MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway.
Zheng Z; Qu JQ; Yi HM; Ye X; Huang W; Xiao T; Li JY; Wang YY; Feng J; Zhu JF; Lu SS; Yi H; Xiao ZQ
Cell Death Dis; 2017 Jun; 8(6):e2855. PubMed ID: 28569771
[TBL] [Abstract][Full Text] [Related]
8. Nasopharyngeal cancer combination chemoradiation therapy based on folic acid modified, gefitinib and yttrium 90 co-loaded, core-shell structured lipid-polymer hybrid nanoparticles.
Yugui F; Wang H; Sun D; Zhang X
Biomed Pharmacother; 2019 Jun; 114():108820. PubMed ID: 30951947
[TBL] [Abstract][Full Text] [Related]
9. Pectolinarigenin Suppresses the Tumor Growth in Nasopharyngeal Carcinoma.
Wang C; Cheng Y; Liu H; Xu Y; Peng H; Lang J; Liao J; Liu H; Liu H; Fan J
Cell Physiol Biochem; 2016; 39(5):1795-1803. PubMed ID: 27744436
[TBL] [Abstract][Full Text] [Related]
10. Polyphyllin G induce apoptosis and autophagy in human nasopharyngeal cancer cells by modulation of AKT and mitogen-activated protein kinase pathways in vitro and in vivo.
Chen JC; Hsieh MJ; Chen CJ; Lin JT; Lo YS; Chuang YC; Chien SY; Chen MK
Oncotarget; 2016 Oct; 7(43):70276-70289. PubMed ID: 27602962
[TBL] [Abstract][Full Text] [Related]
11. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
Wang B; Gu Q; Li J
Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
[TBL] [Abstract][Full Text] [Related]
12. Highly Uniform Synthesis of Selenium Nanoparticles with EGFR Targeting and Tumor Microenvironment-Responsive Ability for Simultaneous Diagnosis and Therapy of Nasopharyngeal Carcinoma.
Huang J; Huang W; Zhang Z; Lin X; Lin H; Peng L; Chen T
ACS Appl Mater Interfaces; 2019 Mar; 11(12):11177-11193. PubMed ID: 30821437
[TBL] [Abstract][Full Text] [Related]
13. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol inhibits human nasopharyngeal carcinoma cell growth via blocking pAkt/p70S6K signaling pathways.
Zhang M; Zhou X; Zhou K
Int J Mol Med; 2013 Mar; 31(3):621-7. PubMed ID: 23314035
[TBL] [Abstract][Full Text] [Related]
15. A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery.
Lee TY; Wu HC; Tseng YL; Lin CT
Cancer Res; 2004 Nov; 64(21):8002-8. PubMed ID: 15520208
[TBL] [Abstract][Full Text] [Related]
16. Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer.
Yeh CY; Hsiao JK; Wang YP; Lan CH; Wu HC
Biomaterials; 2016 Aug; 99():1-15. PubMed ID: 27209258
[TBL] [Abstract][Full Text] [Related]
17. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis.
Xu Z; Fang S; Zuo Y; Zhang Y; Cheng R; Wang Q; Yang Z; Cai W; Ma J; Yang X; Gao G
Cancer Sci; 2011 Oct; 102(10):1789-98. PubMed ID: 21707863
[TBL] [Abstract][Full Text] [Related]
18. Specific targeting of nasopharyngeal carcinoma cell line CNE1 by C225-conjugated ultrasmall superparamagnetic iron oxide particles with magnetic resonance imaging.
Liu D; Chen C; Hu G; Mei Q; Qiu H; Long G; Hu G
Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):301-6. PubMed ID: 21345916
[TBL] [Abstract][Full Text] [Related]
19. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
[TBL] [Abstract][Full Text] [Related]
20. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
